Abstract:Uncovering the regulators of cellular aging will unravel the complexity of aging biology and identify potential therapeutic interventions to delay the onset and progress of chronic, aging-related diseases. In this work, we systematically compared genesets involved in regulating the lifespan of Saccharomyces cerevisiae (a powerful model organism to study the cellular aging of humans) and those with expression changes under rapamycin treatment. Among the functionally uncharacterized genes in the overlap set, YBR238C stood out as the only one downregulated by rapamycin and with an increased chronological and replicative lifespan upon deletion. We show that YBR238C and its paralog RMD9 oppositely affect mitochondria and aging. YBR238C deletion increases the cellular lifespan by enhancing mitochondrial function. Its overexpression accelerates cellular aging via mitochondrial dysfunction. We find that the phenotypic effect of YBR238C is largely explained by HAP4 - and RMD9 -dependent mechanisms. Furthermore, we find that genetic- or chemical-based induction of mitochondrial dysfunction increases TORC1 (Target of Rapamycin Complex 1) activity that, subsequently, accelerates cellular aging. Notably, TORC1 inhibition by rapamycin (or deletion of YBR238C ) improves the shortened lifespan under these mitochondrial dysfunction conditions in yeast and human cells. The growth of mutant cells (a proxy of TORC1 activity) with enhanced mitochondrial function is sensitive to rapamycin whereas the growth of defective mitochondrial mutants is largely resistant to rapamycin compared to wild type. Our findings demonstrate a feedback loop between TORC1 and mitochondria (the TO RC1– MI tochondria– TO RC1 (TOMITO) signaling process) that regulates cellular aging processes. Hereby, YBR238C is an effector of TORC1 modulating mitochondrial function.

KLHL22 Activates Amino-Acid-dependent Mtorc1 Signalling to Promote Tumorigenesis and Ageing.

Regulatory Function of Phosphorylation and Ubiquitination on The TORC1 Signaling Pathway

The Mtor–s6k Pathway Links Growth Signalling to DNA Damage Response by Targeting RNF168

The Ubiquitination of Rag A GTPase by RNF152 Negatively Regulates Mtorc1 Activation.

mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype

Rapalink-1 reveals novel mTOR-dependent genes and an agmatinergic axis-based metabolic feedback regulating mTOR activity and lifespan

Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing

mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress

Disruption of the Keap1-mTORC2 Axis by Cancer-Derived Keap1/mLST8 Mutations Leads to Oncogenic Mtorc2-Akt Activation.

Targeting the Mtor-Deptor Pathway by CRL E3 Ubiquitin Ligases: Therapeutic Application

mTORC1-CTLH E3 ligase regulates the degradation of HMG-CoA synthase 1 through the Pro/N-degron pathway

SAR1B senses leucine levels to regulate mTORC1 signalling

Post-translational Regulation of the Mtorc1 Pathway: A Switch That Regulates Metabolism-Related Gene Expression

MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

mTORC2: A neglected player in aging regulation

KICSTOR Recruits GATOR1 to the Lysosome and is Necessary for Nutrients to Regulate Mtorc1.

CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth

Hypothalamic Mtorc2 is Essential for Metabolic Health and Longevity

The mTORC1-autophagy pathway is a target for senescent cell elimination

mTORC1 phosphorylates and stabilizes LST2 to negatively regulate EGFR

Uncharacterized yeast gene YBR238C , an effector of TORC1 signaling in a mitochondrial feedback loop, accelerates cellular aging via HAP4 - and RMD9 -dependent mechanisms